Efforts by CMS to reform the 340B Drug Pricing Program aim to decrease financial incentives that place revenue over patients' health outcomes and access to care.
Prescription Drugs & Other Medical Products
Drugs and other medical products greatly impact human health and the health care system. ASPE conducts a variety of research in this area, including work related to medical product development and regulation; medical product markets, pricing and competition; prescription drug benefits and spending on medical products; medical product supply chains; and medical product safety.
Noteworthy
Reports
Displaying 1 - 10 of 217. 10 per page. Page 1.
Advanced SearchResearch Brief
Children in Child Welfare are More Likely to be Prescribed Psychotropic Medication than Other Children on Medicaid: Findings from Florida and Kentucky
The use of psychotropic medications in children is a complex issue for parents, caregivers, health care professionals, researchers, and policymakers. Psychotropic medications are used to treat behavioral health conditions. When these medications are prescribed appropriately, they can be effective in managing behavioral health symptoms.
ASPE Issue Brief
The Changing Insulin Affordability Landscape: Lower Out-of-Pocket Costs and Expanded Access Pathways
KEY POINTS
Research Brief
Estimating Emergency Department Utilization of Select Drugs during Extreme Heat Events
We modeled the excess utilization of three commonly used drugs that treat heat-related illness in emergency departments during extreme heat events, using literature-derived estimates of emergency department visit rates for heat-related illness on extreme heat days and drug utilization rates from medical claims data.We estimate that extreme heat is associated with an average of 34,
Report
Defining and Measuring the Resilience, Criticality, and Vulnerability of Medical Product Supply Chains
Recent disruptions in medical product supply chains have highlighted the need for stronger, more coordinated approaches to ensuring reliable access to medical products.
ASPE Issue Brief
Measuring Innovation of Medical Products
Increasing innovation in medical products is a policy priority. A first step to understanding changes in the level of innovation is to determine how to measure the baseline of innovation. Existing research employs a variety of measurement methods–scientific, therapeutic, and economic measures–to study trends in medical product (e.g., drugs, biologics, devices) innovation.
Report
Understanding the Role of Patient Advocacy Organizations in Funding Medical Product Research and Development
Patient advocacy organizations (PAOs) play a key role in medical product development. Many PAOs raise money to fund medical product development activities – such as basic science research, preclinical research, and clinical trials - for their condition of focus, whereas others fund or develop resources such as biobanks or patient registries to support the research community.
Report
U.S. Biosimilar Market Entry Challenges and Facilitating Factors
There is ongoing interest in understanding ways to reduce drug prices and improve patient access to prescription drugs in the U.S. The estimated savings to the U.S. healthcare system from the use of biosimilars are significant.
ASPE Data Point
U.S. Population Prevalence of Prescription Psychiatric Medication Use Among Children and Adolescents, 2006-2023
Recent federal policy discussions have renewed focus on psychiatric medication use among children and adolescents. Psychiatric medications represent one evidence-based component within a spectrum of effective treatments for pediatric mental illness, alongside psychotherapy, family-based interventions, and school supports.